Core Points - Lihexing announced an adjustment to the business scope of its subsidiary, Lihexing Intelligent Equipment (Suzhou) Co., Ltd., to meet operational management needs [1] - The company has completed the necessary industrial and commercial change registration procedures and received a new business license from the Suzhou Industrial Park Administrative Approval Bureau [1]

Group 1: Financial Performance - The company's net profit has significantly decreased year-on-year due to a reduction in sales revenue and a lower gross profit margin, which is attributed to intensified market competition [3] - The gross profit margin is expected to improve through product structure optimization, cost control, and increased R&D investment [3] Group 2: Capital Raising and Investment Strategy - The company plans to raise funds through a simplified procedure for a private placement to invest in the "R&D and industrialization of precision components for semiconductor equipment" project [3][4] - The focus of potential acquisitions will be on high-quality assets in the upstream and downstream sectors, particularly in robotics and semiconductor precision components [3] Group 3: Future Outlook and Market Position - The company maintains an optimistic outlook for future performance, aiming to become a leading provider of intelligent manufacturing solutions [4] - The company will focus on high-value-added products in the fields of new energy vehicles and communication technology, with a strategy to enhance collaboration with key clients [4] - The domestic substitution rate for precision components is projected to rise from 25% to 45%, creating significant market opportunities [4]

Core Viewpoint - The stock price fluctuations of Lihexing (301013) are influenced by multiple factors, and the company is actively working on business collaboration and resource integration to enhance its management level [1] Group 1 - The company responded to investor inquiries on October 24 regarding stock price volatility [1] - The company emphasizes the importance of improving operational management through business synergy and resource integration [1]

证券代码：301013 证券简称：利和兴 公告编号：2025-072 近日，利和兴苏州完成了相关工商变更备案登记手续，并取得了由苏州工业园区行政 审批局换发的《营业执照》。相关信息如下： | 变更 事项 | 变更前 | 变更后 | | --- | --- | --- | | | 一般项目：智能基础制造装备制造；智能基 | | | | 础制造装备销售；技术服务、技术开发、技 | | | | | 一般项目：智能基础制造装备制造；智能基础制 | | | 术咨询、技术交流、技术转让、技术推广； | 造装备销售；技术服务、技术开发、技术咨询、 | | | 货物进出口；技术进出口；进出口代理；工 | | | | | 技术交流、技术转让、技术推广；货物进出口； | | | 业机器人制造；工业机器人销售；工业机器 | | | | | 技术进出口；进出口代理；工业机器人制造；工 | | 经营 | 人安装、维修；信息系统集成服务；信息咨 | 业机器人销售；工业机器人安装、维修；信息系 | | 范围 | 询服务（不含许可类信息咨询服务）；机械 | | | | 零件、零部件销售；特种设备销售；通用设 | 统集成服务；信息咨询服务（不 ...

Core Viewpoint - Lihexing (301013.SZ) reported a decline in revenue and a significant net loss for the first three quarters of 2025, indicating financial challenges for the company [1] Financial Performance - The company's operating revenue for the first three quarters was 327 million yuan, representing a year-on-year decrease of 8.85% [1] - The net loss attributable to shareholders of the listed company was 65.883 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 65.439 million yuan [1] - The basic loss per share was 0.28 yuan [1]

Group 1 - The company Lihexing (SZ 301013) held its 15th meeting of the fourth board of directors on October 23, 2025, to discuss various proposals, including the completion of certain fundraising projects and the permanent allocation of surplus funds to working capital [1] - For the year 2024, the company's revenue composition is as follows: 74.42% from specialized equipment manufacturing and 25.58% from electronic components manufacturing [1] - As of the report date, Lihexing has a market capitalization of 6.7 billion yuan [1] Group 2 - The Chinese innovative pharmaceutical sector has generated $80 billion in overseas licensing deals this year, indicating a robust market for biopharmaceuticals [1] - Despite the hot secondary market for biopharmaceuticals, the primary market is experiencing a cooling in fundraising activities, as noted by investor Lu Gang [1]

Group 1 - The core point of the article highlights that Lihexing (SZ 301013) reported a revenue of approximately 327 million yuan for the first three quarters of 2023, representing a year-on-year decrease of 8.85% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 65.88 million yuan, with basic earnings per share reflecting a loss of 0.28 yuan [1] - As of the report date, Lihexing's market capitalization stands at 6.7 billion yuan [1] Group 2 - The article also mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion US dollars this year, indicating a robust performance in the biopharmaceutical secondary market [1] - A dialogue with Lu Gang, a partner at Chuangdongfang Investment, points out the contrast between the hot secondary market and the cooling fundraising environment in the primary market for the biopharmaceutical sector [1]

国联民生证券承销保荐有限公司关于 深圳市利和兴股份有限公司首次公开发行股票 部分募投项目结项并将节余募集资金永久补充流动资金 及注销募集资金专户的核查意见 国联民生证券承销保荐有限公司（以下简称"国联民生承销保荐"、"保荐机 构"）作为深圳市利和兴股份有限公司（以下简称"利和兴"、"公司"）首次公开 发行股票并在创业板上市的持续督导保荐机构，根据《证券发行上市保荐业务管 理办法》《上市公司募集资金监管规则》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等有关法律法规和规范性文件的要求，国联民生承销保荐对利和兴首次公开发行 股票部分募投项目结项并将节余募集资金永久补充流动资金及注销募集资金专 户进行了核查，发表如下核查意见： 一、募集资金的基本情况 经中国证券监督管理委员会"证监许可[2021]1633 号"《关于同意深圳市利 和兴股份有限公司首次公开发行股票注册的批复》的批复，公司首次向社会公开 发行人民币普通股（A 股）38,957,176 股，每股发行价格 8.72 元，新股发行募集 资金总额为 33,970.66 万元，扣除发行费用 5 ...

关于首次公开发行股票部分募投项目结项 并将节余募集资金永久补充流动资金 证券代码：301013 证券简称：利和兴 公告编号：2025-071 深圳市利和兴股份有限公司 及注销募集资金专户的公告 注：智能装备制造基地项目的"累计已投入募集资金金额"包含了该项目实施期间的闲置募 集资金现金管理利息收入 157.44 万元，该项目已结项。 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市利和兴股份有限公司（以下简称"公司"）于 2025 年 10 月 23 日召开第 四届董事会第十五次会议，审议通过了《关于首次公开发行股票部分募投项目结项 并将节余募集资金永久补充流动资金及注销募集资金专户的议案》，同意公司将首 次公开发行股票募投项目"研发中心建设项目"结项，并将节余募集资金 485.32 万 元（含现金管理取得的理财收益及活期利息收入，具体金额以资金转出当日银行结 算余额为准）永久补充流动资金，用于公司日常经营活动。节余募集资金永久补充 流动资金完成后，公司将按要求注销募集资金专户，公司与保荐机构、开户银行签 署的募集资金专户监管协议随之终止。 根据《深圳证 ...

证券代码：301013 证券简称：利和兴 公告编号：2025-069 深圳市利和兴股份有限公司 第四届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 深圳市利和兴股份有限公司（以下简称"公司"）第四届董事会第十五次会议通知 于 2025 年 10 月 14 日以电子邮件等通讯方式发出，于 2025 年 10 月 23 日在公司汇德会 议室以现场结合视频方式召开。会议由公司董事长林宜潘先生主持，应出席董事 7 人， 实际出席董事 7 人，公司全体高级管理人员列席了会议。 本次会议的召集、召开和表决程序符合有关法律、法规和《公司章程》的规定。 二、董事会会议审议情况 （二）审议通过《关于首次公开发行股票部分募投项目结项并将节余募集资金永久 1/2 补充流动资金及注销募集资金专户的议案》 董事会认为：鉴于公司首次公开发行股票募集资金投资项目"研发中心建设项目" 已达到可使用状态，为最大限度地发挥募集资金的使用效益，结合公司实际经营情况， 同意公司将"研发中心建设项目"结项，并将节余募集资金永久补充流动资金，用于与 ...